Trethera corporation
WebMar 15, 2024 · LOS ANGELES, March 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation ("Trethera"), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism ... WebApr 27, 2024 · For instance, as Trethera Corporation’s Chief Operating Officer and Director of R&D, Nathan was instrumental in rapidly advancing a first-in-class anti-cancer agent …
Trethera corporation
Did you know?
WebJan 31, 2024 · LOS ANGELES, Jan. 31, 2024 /PRNewswire/ -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, announced the nomination and acceptance of Timothy Donahue to Trethera's Board of Directors by unanimous vote of … Webalumni and giving ... more
WebAug 30, 2024 · LOS ANGELES, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) … WebJan 5, 2024 · Trethera Corporation is a privately-held biotechnology company based in Santa Monica, CA, whose mission is to address the unmet medical needs of patients with …
WebFounders Caius Radu, David Nathanson, Johannes Czernin, Michael Jung, Owen Witte. Operating Status Active. Last Funding Type Grant. Legal Name Trethera Corp. Company … WebFeb 5, 2024 · LOS ANGELES, Feb. 5, 2024 /PRNewswire/ -- Trethera Corporation, a biopharmaceutical company committed to developing novel drugs targeting cellular...
WebJun 1, 2024 · LOS ANGELES, June 01, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism ...
WebTRETHERA CORPORATION is a California Stock Corporation - Out Of State - Stock filed on August 12, 2015. The company's filing status is listed as Active and its File Number is 3816163. The Registered Agent on file for this company is Carl Mckinzie and is located at 10900 Wilshire Blvd Suite 850, Los Angeles, CA 90024. lakeshore city park chelanWebAug 30, 2024 · LOS ANGELES, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) … lakeshore clinic burlingtonWebJan 24, 2024 · LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism ... hello molly store credit onlyWebJun 2, 2024 · The U.S. Department of Justice and the Securities and Exchange Commission have separately indicted Marc Schessel and his company, Scworx Corp., for making false … hello molly unidaysWebApr 17, 2024 · Trethera Corporation was founded in 2013 and most recently raised $19.1M in seed-stage capital. In upcoming news, Trethera is presenting at the NYC Oncology Investor Conference, occurring on May 8-9 at the office of Wilson Sonsini in New York City. Learn more and register to attend the conference at www.nyconcologyconference.com. hello molly usWebJan 31, 2024 · LOS ANGELES, Jan. 31, 2024 /PRNewswire/ -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs target... lakeshore cinema manitowoc wiWebOct 25, 2024 · About Trethera Corporation Trethera is a privately-held biopharmaceutical company dedicated to developing novel treatments for cancers with high unmet needs. … lakeshore cinema manitowoc facebook